Open AccessCapecitabine with radiation is an effective adjuvant therapy in gastric cancers
Author(s) -
Chee Kian Tham,
Su Pin Choo,
Dennis Poon,
Han Chong Toh,
Simon Yew Kuang Ong,
Sze Huey Tan,
Michael Lian Chek Wang,
Kian Fong Foo
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i29.3709
Subject(s) - medicine , capecitabine , epirubicin , chemotherapy , radiation therapy , gastroenterology , fluorouracil , oncology , cancer , mucositis , stage (stratigraphy) , surgery , cyclophosphamide , colorectal cancer , paleontology , biology
To analyze the outcome of patients who received concurrent capecitabine (Xeloda) and radiation (XRT) compared to the established concurrent 5-fluorouracil (5-FU) with radiation (5FU-RT) and fluoropyrimidine-based chemotherapy alone as adjuvant treatment in gastric cancers.